BHB Newsletter

BHB contributes to DGDA’s Coalition of Interested Partners to reach WHO’s maturity level 3 for vaccine regulations

BHB is a member of DGDA’s Coalition of Interested Partners, which is helping it attain maturity level 3 for vaccine regulation based on the World Health Organization (WHO) Global Benchmarking Tool. BHB is an active member of this coalition. The coalition met at DGDA headquarters on 3 October 2022 in collaboration with WHO. WHO will audit DGDA in 2023 to verify compliance with the requirements, which BHB supports. Dr Iftakhar Hasan Khan, Principal Technical Adviser, Mominur Rahman, Technical Adviser, and Raian Amzad, Technical Adviser, presented at the meeting.